Modelling the long QT syndrome with induced pluripotent stem cells
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The ability to generate patient-specific human induced pluripotent stem cells (iPSCs) offers a new paradigm for modelling human disease and for individualizing drug testing. Congenital long QT syndrome (LQTS) is a familial arrhythmogenic syndrome characterized by abnormal ion channel function and sudden cardiac death. Here we report the development of a patient/disease-specific human iPSC line from a patient with type-2 LQTS (which is due to the A614V missense mutation in the KCNH2 gene). The generated iPSCs were coaxed to differentiate into the cardiac lineage. Detailed whole-cell patch-clamp and extracellular multielectrode recordings revealed significant prolongation of the action-potential duration in LQTS human iPSC-derived cardiomyocytes (the characteristic LQTS phenotype) when compared to healthy control cells. Voltage-clamp studies confirmed that this action-potential-duration prolongation stems from a significant reduction of the cardiac potassium current I(Kr). Importantly, LQTS-derived cells also showed marked arrhythmogenicity, characterized by early-after depolarizations and triggered arrhythmias. We then used the LQTS human iPSC-derived cardiac-tissue model to evaluate the potency of existing and novel pharmacological agents that may either aggravate (potassium-channel blockers) or ameliorate (calcium-channel blockers, K(ATP)-channel openers and late sodium-channel blockers) the disease phenotype. Our study illustrates the ability of human iPSC technology to model the abnormal functional phenotype of an inherited cardiac disorder and to identify potential new therapeutic agents. As such, it represents a promising paradigm to study disease mechanisms, optimize patient care (personalized medicine), and aid in the development of new therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Various cell models built with iPSC derivatives have been shown to resemble in vivo or primary cell counterparts at transcriptional, cellular, and functional levels whilst leaving little interference to the genetic content [4,5,6,7].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
In the citing paper
“Type-2 LQTS patients’ iPSC-derived cardiomyocytes showed that a mutation in KCNH2 causes action-potential-duration prolongation by reducing the cardiac potassium current IKr and dysfunction of the sodium ion channel [7,8,9].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [7]
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Reprogramming of human somatic cells to pluripotency with defined factors
Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436
Disease-Specific Induced Pluripotent Stem Cells.
Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., Segev, H., Amit, M., Gepstein, A., Livne, E., Binah, O., Itskovitz‐Eldor, J., & Gepstein, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12131 · Cited by 1,814
Self-citationHuangfu, D., Maehr, R., Guo, W., Eijkelenboom, A., Snitow, M., Chen, A. E., & Melton, D. A. (2008) · Nature Biotechnology · doi:10.1038/nbt1418 · Cited by 1,606
hERG potassium channels and cardiac arrhythmia
Sanguinetti, M. C., & Tristani-Firouzi, M. (2006) · Nature · doi:10.1038/nature04710 · Cited by 1,572
Kehat, I., Kenyagin‐Karsenti, D., Snir, M., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112131 · Cited by 1,536
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Cited by
Items 301–400 of 1,000
Recent progress of iPSC technology in cardiac diseases
Funakoshi, S., & Yoshida, Y. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03172-3 · Cited by 52
Seibertz, F., Sutanto, H., Dülk, R., Pronto, J. R. D., Springer, R., Rapedius, M., Liutkute, A., Ritter, M., Jung, P., Stelzer, L., et al. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-022-00973-0 · Cited by 50
The evolving field of induced pluripotency: Recent progress and future challenges
Sommer, C., & Mostoslavsky, G. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24155 · Cited by 51
MicroRNAs: Important Regulators of Induced Pluripotent Stem Cell Generation and Differentiation
Zeng, Z., Lin, X., Tan, L.-L., Liu, Y., Qu, K., & Wang, Z. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9785-6 · Cited by 46
CRISPR-based functional genomics screening in human-pluripotent-stem-cell-derived cell types
Li, K., Ouyang, M., Zhan, J., & Tian, R. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100300 · Cited by 61
Skoglund, G., Lainé, J., Darabi, R., Fournier, E., Perlingeiro, R. C. R., & Tabti, N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322258111 · Cited by 45
Spatiotemporally controlled delivery of soluble factors for stem cell differentiation
Kawada, J., Kimura, H., Akutsu, H., Sakai, Y., & Fujii, T. (2012) · Lab on a Chip · doi:10.1039/c2lc40268h · Cited by 45
Doyle, M. J., Lohr, J. L., Chapman, C. S., Koyano‐Nakagawa, N., Garry, M. G., & Garry, D. J. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-015-9596-6 · Cited by 48
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes
Dell’Era, P. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.329 · Cited by 42
Stem cell biology and drug discovery
Rubin, L. L., & Haston, K. M. (2011) · BMC Biology · doi:10.1186/1741-7007-9-42 · Cited by 48
Zatti, S., Martewicz, S., Serena, E., Uno, N., Giobbe, G., Kazuki, Y., Oshimura, M., & Elvassore, N. (2014) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2013.1 · Cited by 43
Gu, X., Yeung, S. Y., Chadda, A., Poon, E. N.-Y., Boheler, K. R., & Hsing, I. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800248 · Cited by 48
Stem Cells in Cardiovascular Medicine: Historical Overview and Future Prospects
Samak, M., & Hinkel, R. (2019) · Cells · doi:10.3390/cells8121530 · Cited by 46
Qi, T., Wu, F., Xie, Y., Gao, S., Li, M., Pu, J., Li, D., Lan, F., & Wang, Y. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.590581 · Cited by 47
Zheng, Z., Wu, Y., Qian, D., & Jiangfang, L. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173813 · Cited by 49
Precision Medicine and cardiac channelopathies: when dreams meet reality
Gnecchi, M., Sala, L., & Schwartz, P. J. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab007 · Cited by 46
Regenerative strategies for kidney engineering
Montserrat, N., Garreta, E., & Belmonte, J. C. I. (2016) · FEBS Journal · doi:10.1111/febs.13704 · Cited by 47
Genetics and Disease of Ventricular Muscle
Fatkin, D., Seidman, C. E., & Seidman, J. G. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a021063 · Cited by 48
Hong, L., Zhang, M., Ly, O. T., Chen, H., Sridhar, A., Lambers, E., Chalazan, B., Youn, S.-W., Maienschein-Cline, M., Feferman, L., et al. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2021.04.019 · Cited by 44
“There is increasing interest in developing cellular models of disease that are genetically matched to specific patients using human induced pluripotent stem cells (iPSCs) (Itzhaki et al., 2011; Moretti et al., 2010).”
BackgroundRecent technological updates and clinical applications of induced pluripotent stem cells
Diecke, S., Jung, S. M., Lee, J., & Ju, J. H. (2014) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2014.29.5.547 · Cited by 51
Induced Pluripotent Stem Cells for the Study of Cardiovascular Disease
Savla, J. J., Nelson, B., Perry, C. N., & ADLER, E. D. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.05.038 · Cited by 48
Barbuti, A., Benzoni, P., Campostrini, G., & Dell'Era, P. (2016) · Developmental Dynamics · doi:10.1002/dvdy.24455 · Cited by 42
Multiparametric slice culture platform for the investigation of human cardiac tissue physiology
Qiao, Y., Dong, Q., Li, B., Obaid, S. N., Miccile, C., Yin, R. T., Talapatra, T., Lin, Z., Li, S., Li, Z., et al. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.06.001 · Cited by 51
The march of pluripotent stem cells in cardiovascular regenerative medicine
Abou-Saleh, H., Zouein, F. A., EL‐Yazbi, A. F., Sanoudou, D., Raynaud, C. M., Rao, C., Pintus, G., Dehaini, H., & Eid, A. H. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0947-5 · Cited by 51
Brandão, K. O., van den Brink, L., Miller, D. C., Grandela, C., van Meer, B. J., Mol, M. P. H., de Korte, T., Tertoolen, L. G. J., Mummery, C. L., Sala, L., et al. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.10.005 · Cited by 43
Rabieh, N., Ojovan, S. M., Shmoel, N., Erez, H., Maydan, E., & Spira, M. E. (2016) · Scientific Reports · doi:10.1038/srep36498 · Cited by 49
Yoshimitsu, R., Hattori, K., Sugiura, S., Kondo, Y., Yamada, R., Tachikawa, S., Satoh, T., Kurisaki, A., Ohnuma, K., Asashima, M., et al. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25150 · Cited by 43
Systems biology and cardiac arrhythmias
Grace, A. A., & Roden, D. M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61462-7 · Cited by 44
Tidball, A. M., & Parent, J. M. (2015) · Stem Cells · doi:10.1002/stem.2203 · Cited by 47
Pesce, M., Agostoni, P., Bøtker, H. E., Brundel, B. J. J. M., Davidson, S. M., Caterina, R. D., Ferdinandy, P., Girão, H., Gyöngyösi, M., Hulot, J., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab201 · Cited by 44
Developmental and Functional Nature of Human iPSC Derived Motoneurons
Stockmann, M., Linta, L., Föhr, K. J., Boeckers, A., Ludolph, A. C., Kuh, G. F., Udvardi, P. T., Proepper, C., Storch, A., Kleger, A., et al. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9329-4 · Cited by 46
Song, L., Awari, D. W., Han, E. Y., Uche-Anya, E. N., Park, S.-H. E., Yabe, Y., Chung, W. K., & Yazawa, M. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0245 · Cited by 44
iPSCs and small molecules: a reciprocal effort towards better approaches for drug discovery
Zhang, R., Zhang, L., & Xie, X. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.21 · Cited by 45
Toward Precision Medicine for Neurological and Neuropsychiatric Disorders
Gibbs, R. M., Lipnick, S., Bateman, J., Chen, L., Cousins, H. C., Hubbard, E. G., Jowett, G. M., LaPointe, D. S., McGredy, M., Odonkor, M. N., et al. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.05.019 · Cited by 42
Therapeutic genome editing in cardiovascular diseases
Nishiga, M., Qi, L. S., & Wu, J. C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.02.003 · Cited by 44
Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering
Gähwiler, E. K. N., Motta, S. E., Martin, M., Nugraha, B., Hoerstrup, S. P., & Emmert, M. Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.639699 · Cited by 45
Heart-on-a-chip systems: disease modeling and drug screening applications
Butler, D., & Reyes, D. R. (2024) · Lab on a Chip · doi:10.1039/d3lc00829k · Cited by 47
Crotti, L., Neves, R., Dagradi, F., Musu, G., Giannetti, F., Bos, J. M., Barbieri, M., Cerea, P., Giovenzana, F. L. F., Torchio, M., et al. (2024) · Circulation · doi:10.1161/circulationaha.124.068959 · Cited by 43
Induced pluripotent stem cells for cardiac repair
Zwi‐Dantsis, L., & Gepstein, L. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1078-2 · Cited by 45
Self-citationInduced Pluripotent Stem Cell Potential in Medicine, Specifically Focused on Reproductive Medicine
Botman, O., & Wyns, C. (2014) · Frontiers in Surgery · doi:10.3389/fsurg.2014.00005 · Cited by 42
Kiviaho, A., Ahola, A., Larsson, K., Penttinen, K., Swan, H., Pekkanen-Mattila, M., Venäläinen, H., Paavola, K., Hyttinen, J., & Aalto‐Setälä, K. (2015) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2015.04.008 · Cited by 41
Mechanotransduction and Metabolism in Cardiomyocyte Microdomains
Pasqualini, F. S., Nesmith, A. P., Horton, R. E., Sheehy, S. P., & Parker, K. K. (2016) · BioMed Research International · doi:10.1155/2016/4081638 · Cited by 43
Eisen, B., Jehuda, R. B., Cuttitta, A. J., Mekies, L. N., Shemer, Y., Baskin, P., Reiter, I., Willi, L., Freimark, D., Gherghiceanu, M., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14124 · Cited by 42
Riedel, M., Jou, C. J., Lai, S., Lux, R. L., Moreno, A. P., Spitzer, K. W., Christians, E., Tristani-Firouzi, M., & Benjamin, I. J. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.04.017 · Cited by 44
Understanding cardiovascular disease: a journey through the genome (and what we found there)
Lara‐Pezzi, E., Dopazo, A., & Manzanares, M. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.009787 · Cited by 43
Induced pluripotent stem cells as a model for telomeric abnormalities in ICF type I syndrome
Sagie, S., Ellran, E., Katzir, H., Shaked, R., Yehezkel, S., Laevsky, I., Ghanayim, A., Geiger, D., Tzukerman, M., & Selig, S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu071 · Cited by 42
Molecular and cellular neurocardiology in heart disease
Habecker, B. A., Bers, D. M., Birren, S. J., Chang, R. B., Herring, N., Kay, M. W., Li, D., Mendelowitz, D., Mongillo, M., Montgomery, J. M., et al. (2024) · The Journal of Physiology · doi:10.1113/jp284739 · Cited by 43
Modeling Inherited Cardiac Disorders: A Cell Is Worth a Thousand Genes
Sallam, K., Kodo, K., & Wu, J. C. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0182 · Cited by 42
Fabrication of omentum-based matrix for engineering vascularized cardiac tissues
Shevach, M., Soffer-Tsur, N., Fleischer, S., Shapira, A., & Dvir, T. (2014) · Biofabrication · doi:10.1088/1758-5082/6/2/024101 · Cited by 44
Hartung, S., Schwanke, K., Haase, A., David, R., Franz, W., Martin, U., & Zweigerdt, R. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0351 · Cited by 47
Lei, C. L., Wang, K., Clerx, M., Johnstone, R. H., Hortigon-Vinagre, M. P., Zamora, V., Allan, A., Smith, G. L., Gavaghan, D. J., Mirams, G. R., et al. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00986 · Cited by 40
Real-time Measurement of Biomagnetic Vector Fields in Functional Syncytium Using Amorphous Metal
Nakayama, S., & Uchiyama, T. (2015) · Scientific Reports · doi:10.1038/srep08837 · Cited by 40
The Future of Cardiovascular Regenerative Medicine
Lee, R. T., & Walsh, K. X. (2016) · Circulation · doi:10.1161/circulationaha.115.019214 · Cited by 45
A deep learning platform to assess drug proarrhythmia risk
Serrano, R., Feyen, D. A. M., Bruyneel, A. A. N., Hnatiuk, A. P., Vu, M. M., Amatya, P. L., Perea‐Gil, I., Prado, M., Seeger, T., Wu, J. C., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.12.002 · Cited by 38
Subtype-specific cardiomyocytes for precision medicine: Where are we now?
Zhao, M., Shao, N., & Garg, V. (2020) · Stem Cells · doi:10.1002/stem.3178 · Cited by 41
Evolution of mathematical models of cardiomyocyte electrophysiology
Amuzescu, B. P., Airini, R., Epureanu, F. B., Mann, S. A., Knott, T., & Radu, B. M. (2021) · Mathematical Biosciences · doi:10.1016/j.mbs.2021.108567 · Cited by 46
Davis, J. A., Chouman, A., Creech, J., da Rocha, A. M., Ponce‐Balbuena, D., Jiménez‐Vázquez, E. N., Nichols, R., Lozhkin, A. P., Madamanchi, N. R., Campbell, K. F., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.134368 · Cited by 43
Isolation and Characterization of Embryonic Stem Cell-Derived Cardiac Purkinje Cells
Maass, K., Shekhar, A., Lu, J., Kang, G., See, F., Kim, E. E., Delgado, C., Shen, S., Cohen, L., & Fishman, G. I. (2015) · Stem Cells · doi:10.1002/stem.1921 · Cited by 37
Differentiation and Contractile Analysis of GFP‐Sarcomere Reporter hiPSC‐Cardiomyocytes
Sharma, A., Toepfer, C. N., Schmid, M., Garfinkel, A. C., & Seidman, C. E. (2018) · Current Protocols in Human Genetics · doi:10.1002/cphg.53 · Cited by 43
Chen, G., Li, S., Karakikes, I., Ren, L., Zi-Ying Chow, M., Chopra, A., Keung, W., Yan, B., Chan, C. W. Y., Costa, K. D., et al. (2015) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002049 · Cited by 38
Mozneb, M., Jenkins, A., Sances, S., Pohlman, S., Workman, M. J., West, D., Ondatje, B. N., El‐Ghazawi, K., Woodbury, A., Garcia, V. J., et al. (2024) · Lab on a Chip · doi:10.1039/d3lc00745f · Cited by 43
Differentiation and enrichment of cardiomyocytes from human pluripotent stem cells
Xu, C. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.03.012 · Cited by 38
Barbuti, A., & Robinson, R. B. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009597 · Cited by 41
Pharmacological activation of IKr in models of long QT Type 2 risks overcorrection of repolarization
Perry, M., Ng, C., Mangala, M. M., Ng, T. Y. M., Hines, A., Liang, W., Xu, M. J. O., Hill, A. P., & Vandenberg, J. I. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz247 · Cited by 41
El‐Battrawy, I., Lang, S., Zhao, Z., Akın, İ., Yücel, G., Meister, S., Patocskai, B., Behnes, M., Rudic, B., Tülümen, E., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166143 · Cited by 44
Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery
Tang, S., Xie, M., Cao, N., & Ding, S. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00789 · Cited by 40
Ruvinov, E., Sapir, Y., & Cohen, S. (2012) · Synthesis lectures on tissue engineering · doi:10.2200/s00437ed1v01y201207tis009 · Cited by 37
Lopez-Izquierdo, A., Warren, M., Riedel, M., Cho, S., Lai, S., Lux, R. L., Spitzer, K. W., Benjamin, I. J., Tristani-Firouzi, M., & Jou, C. J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00344.2014 · Cited by 37
Kraushaar, U., Meyer, T., Hess, D., Gepstein, L., L Mummery, C., R Braam, S., & Guenther, E. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.639358 · Cited by 36
Self-citationChow, M. Z. Y., Boheler, K. R., & Li, R. A. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt308 · Cited by 44
Heart Slice Culture System Reliably Demonstrates Clinical Drug-Related Cardiotoxicity
Miller, J. M., Meki, M., Ou, Q., George, S. A., Gams, A., Abouleisa, R., Tang, X., Ahern, B. M., Giridharan, G. A., El-Baz, A. S., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115213 · Cited by 44
Lam, C. K., & Wu, J. C. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314695 · Cited by 38
iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy
Escribá, R., Larrañaga-Moreira, J. M., Richaud‐Patín, Y., Pourchet, L., Lazis, I., Jiménez‐Delgado, S., Morillas-García, A., Ortiz-Genga, M., Ochoa, J. P., Carreras, D., et al. (2023) · Circulation Research · doi:10.1161/circresaha.122.321951 · Cited by 35
The history, hotspots, and trends of electrocardiogram.
Yang, X., Liu, G., Tong, Y., Yan, H., Xu, Z. F., Chen, Q., Liu, X., Zhang, H.-H., Wang, H., & Tan, S. (2015) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2015.04.018 · Cited by 36
Transcription factors and atrial fibrillation
Mahida, S. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt261 · Cited by 37
Recent advances of induced pluripotent stem cells application in neurodegenerative diseases
Amin, N., Tan, X., Ren, Q., Zhu, N., Botchway, B. O. A., Hu, Z., & Fang, M. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109674 · Cited by 39
Brink, L., Grandela, C., Mummery, C. L., & Davis, R. P. (2020) · Stem Cells · doi:10.1002/stem.3110 · Cited by 38
Jung, P., Seibertz, F., Fakuade, F. E., Ignatyeva, N., Sampathkumar, S., Ritter, M., Li, H., Mason, F. E., Ebert, A., & Voigt, N. (2022) · Basic Research in Cardiology · doi:10.1007/s00395-022-00912-z · Cited by 39
Optimizing Dynamic Interactions between a Cardiac Patch and Inflammatory Host Cells
Freytes, D. O., Santambrogio, L., & Vunjak‐Novakovic, G. (2011) · Cells Tissues Organs · doi:10.1159/000331392 · Cited by 36
Modeling Cancer with Pluripotent Stem Cells
Gingold, J. A., Zhou, R., Lemischka, I. R., & Lee, D. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.07.007 · Cited by 40
Shortcomings of Animal Models and the Rise of Engineered Human Cardiac Tissue
Fine, B. M., & Vunjak‐Novakovic, G. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6b00662 · Cited by 37
Induced pluripotent stem cell technology: Toward the future of cardiac arrhythmias
Gnecchi, M., Stefanello, M., & Mura, M. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.085 · Cited by 36
Hwang, H., Liu, R., Maxwell, J. T., Yang, J., & Xu, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-73801-x · Cited by 39
Lin, H. P., McBride, K. L., Garg, V., & Zhao, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.630069 · Cited by 37
Feng, L., Zhang, J., Lee, C., Kim, G., Liu, F., Petersen, A. J., Lim, E., Anderson, C. L., Orland, K. M., Robertson, G. A., et al. (2021) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.120.009343 · Cited by 37
Ly, O. T., Chen, H., Brown, G. E., Hong, L., Wang, X., Han, Y. D., Pavel, M. A., Sridhar, A., Maienschein‐Cline, M., Chalazan, B., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.155640 · Cited by 37
Trudeau, M. C., Leung, L. M., Roti, E. C. R., & Robertson, G. A. (2011) · The Journal of General Physiology · doi:10.1085/jgp.201110683 · Cited by 35
Zhao, Q., Wang, X., Wang, S., Song, Z., Wang, J., & Ma, J. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0473-x · Cited by 35
Ventricular Tachycardia Due to Triggered Activity
Lerman, B. B., Markowitz, S. M., Cheung, J. W., Thomas, G. R., & Ip, J. E. (2023) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2023.10.033 · Cited by 34
Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies
Sung, R. J., Hsiao, Tien, Lo, C., Juang, J. J., & Wang, Y.-H. (2013) · The Application of Clinical Genetics · doi:10.2147/tacg.s29676 · Cited by 38
Medicina personalizada: diagnóstico genético de cardiopatías/canalopatías hereditarias
Ackerman, M. J., Marcou, C. A., & Tester, D. J. (2013) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.12.010 · Cited by 39
Unchain My Heart: Integrins at the Basis of iPSC Cardiomyocyte Differentiation
Santoro, R., Perrucci, G. L., Gowran, A., & Pompilio, G. (2019) · Stem Cells International · doi:10.1155/2019/8203950 · Cited by 37
Modeling Anesthetic Developmental Neurotoxicity Using Human Stem Cells
Bai, X., Twaroski, D. M., & Bosnjak, Z. J. (2013) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253213495923 · Cited by 34
Kano, F., Nakatsu, D., Noguchi, Y., Yamamoto, A., & Murata, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044127 · Cited by 38
Light-Activated Dynamic Clamp Using iPSC-Derived Cardiomyocytes
Quach, B., Krogh‐Madsen, T., Entcheva, E. G., & Christini, D. J. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.10.018 · Cited by 34
Concise Review: Human Pluripotent Stem Cell-Based Models for Cardiac and Hepatic Toxicity Assessment
Sartipy, P., & Björquist, P. (2011) · Stem Cells · doi:10.1002/stem.631 · Cited by 35
Direct Reprogramming of Fibroblasts into Myocytes to Reverse Fibrosis
Muraoka, N., & Ieda, M. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170301 · Cited by 33
Inherited heart disease – what can we expect from the second decade of human i PS cell research?
Bellin, M., & Mummery, C. L. (2016) · FEBS Letters · doi:10.1002/1873-3468.12285 · Cited by 34
Organoids for Advanced Therapeutics and Disease Models
Kim, S., Cho, A., Min, S., Kim, S., & Cho, S. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800087 · Cited by 34
3D-Culture System for Heart Regeneration and Cardiac Medicine
Kawaguchi, N., Hatta, K., & Nakanishi, T. (2013) · BioMed Research International · doi:10.1155/2013/895967 · Cited by 38
Metadata
- Authors
- Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., Boulos, M., & Gepstein, L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Corresponding author
- Gepstein, Lior
- Venue
- Nature
- Published
- 2011-01-16
- Volume
- 471
- Issue
- 7337
- Pages
- 225-229
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2115644752
- Cited by
- 1,049
- References
- 28
- Citations by year
- 2026: 19 · 2025: 23 · 2024: 46 · 2023: 27 · 2022: 53 · 2021: 68 · 2020: 47 · 2019: 55 · 2018: 60 · 2017: 71 · 2016: 87 · 2015: 97 · 2014: 84 · 2013: 111 · 2012: 123
- FWCI
- 86.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Israel Science Foundation
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- long QT syndrome type 2, KCNH2 mutation, induced pluripotent stem cells, iPSC-derived cardiomyocytes, action potential duration prolongation, drug screening, drug-induced arrhythmia, sudden cardiac death, calcium channel blockers, KATP channel openers, potassium channel blockers, arrhythmogenicity
- MeSH terms
- ERG1 Potassium Channel, Adult, Cells, Cultured, Drug Evaluation, Preclinical, Female, Fibroblasts, Humans, Long QT Syndrome, Models, Biological, Phenotype, Patch-Clamp Techniques, Mutation, Missense, Myocytes, Cardiac, Ether-A-Go-Go Potassium Channels, Embryonic Stem Cells, Cell Transdifferentiation, Induced Pluripotent Stem Cells, Precision Medicine, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.